Global Sodium Bicarbonate Medicine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Bicarbonate Medicine Market Research Report 2024
Sodium bicarbonate is a compound used for the symptomatic treatment of heartburn, acid indigestion, and upset stomach as well as the treatment of metabolic acidosis associated with conditions such as severe renal disease and circulatory insufficiency due to shock.
According to Mr Accuracy reports’s new survey, global Sodium Bicarbonate Medicine market is projected to reach US$ 1343.6 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Bicarbonate Medicine market research.
Key manufacturers engaged in the Sodium Bicarbonate Medicine industry include AdvaCare, Pfizer, Bella Pharmaceuticals, Global Calcium, Trumac Healthcare, Exela Pharma Sciences, LLC, Bayer, Salix Pharmaceuticals, Inc and Brioschi Pharmaceuticals International, LLC, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Bicarbonate Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Bicarbonate Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Bicarbonate Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AdvaCare
Pfizer
Bella Pharmaceuticals
Global Calcium
Trumac Healthcare
Exela Pharma Sciences, LLC
Bayer
Salix Pharmaceuticals, Inc
Brioschi Pharmaceuticals International, LLC
Watson Pharmaceuticals
Hangzhou Minsheng Pharmaceutical Group Co., Ltd
Tianjin Lisheng Pharmaceutical Co., Ltd
Beijing Yanjing Pharmaceutical Co., Ltd
Sichuan Qili Pharmaceutical Co., Ltd
Jilin Aodong Pharmaceutical Group
Guangxi Banzhou Tianlong Pharmaceutical Co., Ltd
Segment by Type
Oral Tablet
Injection
Metabolic Acidosis
Hyperacidity of Stomach
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Bicarbonate Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Sodium Bicarbonate Medicine market is projected to reach US$ 1343.6 million in 2029, increasing from US$ 1057 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Bicarbonate Medicine market research.
Key manufacturers engaged in the Sodium Bicarbonate Medicine industry include AdvaCare, Pfizer, Bella Pharmaceuticals, Global Calcium, Trumac Healthcare, Exela Pharma Sciences, LLC, Bayer, Salix Pharmaceuticals, Inc and Brioschi Pharmaceuticals International, LLC, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Bicarbonate Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Bicarbonate Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Bicarbonate Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AdvaCare
Pfizer
Bella Pharmaceuticals
Global Calcium
Trumac Healthcare
Exela Pharma Sciences, LLC
Bayer
Salix Pharmaceuticals, Inc
Brioschi Pharmaceuticals International, LLC
Watson Pharmaceuticals
Hangzhou Minsheng Pharmaceutical Group Co., Ltd
Tianjin Lisheng Pharmaceutical Co., Ltd
Beijing Yanjing Pharmaceutical Co., Ltd
Sichuan Qili Pharmaceutical Co., Ltd
Jilin Aodong Pharmaceutical Group
Guangxi Banzhou Tianlong Pharmaceutical Co., Ltd
Segment by Type
Oral Tablet
Injection
Segment by Application
Metabolic Acidosis
Hyperacidity of Stomach
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Bicarbonate Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices